2023-06-212024-06-302024-06-30falseSC773299MAKIBEL LIMITED2025-02-12falseiso4217:GBPxbrli:pureSC7732992023-06-21SC7732992024-06-30SC7732992023-06-212024-06-30SC7732992023-06-20SC7732992023-06-20SC7732992023-06-202023-06-20SC773299bus:SmallEntities2023-06-212024-06-30SC773299bus:AuditExempt-NoAccountantsReport2023-06-212024-06-30SC773299bus:FullAccounts2023-06-212024-06-30SC773299bus:PrivateLimitedCompanyLtd2023-06-212024-06-30SC773299core:WithinOneYear2024-06-30SC773299core:AfterOneYear2024-06-30SC773299core:WithinOneYear2023-06-20SC773299core:AfterOneYear2023-06-20SC773299core:ShareCapital2024-06-30SC773299core:SharePremium2024-06-30SC773299core:RevaluationReserve2024-06-30SC773299core:OtherReservesSubtotal2024-06-30SC773299core:RetainedEarningsAccumulatedLosses2024-06-30SC773299core:ShareCapital2023-06-20SC773299core:SharePremium2023-06-20SC773299core:RevaluationReserve2023-06-20SC773299core:OtherReservesSubtotal2023-06-20SC773299core:RetainedEarningsAccumulatedLosses2023-06-20SC773299core:LandBuildings2024-06-30SC773299core:PlantMachinery2024-06-30SC773299core:Vehicles2024-06-30SC773299core:FurnitureFittings2024-06-30SC773299core:OfficeEquipment2024-06-30SC773299core:NetGoodwill2024-06-30SC773299core:IntangibleAssetsOtherThanGoodwill2024-06-30SC773299core:ListedExchangeTraded2024-06-30SC773299core:UnlistedNon-exchangeTraded2024-06-30SC773299core:LandBuildings2023-06-20SC773299core:PlantMachinery2023-06-20SC773299core:Vehicles2023-06-20SC773299core:FurnitureFittings2023-06-20SC773299core:OfficeEquipment2023-06-20SC773299core:NetGoodwill2023-06-20SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-20SC773299core:ListedExchangeTraded2023-06-20SC773299core:UnlistedNon-exchangeTraded2023-06-20SC773299core:LandBuildings2023-06-212024-06-30SC773299core:PlantMachinery2023-06-212024-06-30SC773299core:Vehicles2023-06-212024-06-30SC773299core:FurnitureFittings2023-06-212024-06-30SC773299core:OfficeEquipment2023-06-212024-06-30SC773299core:NetGoodwill2023-06-212024-06-30SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-212024-06-30SC773299core:ListedExchangeTraded2023-06-212024-06-30SC773299core:UnlistedNon-exchangeTraded2023-06-212024-06-30SC773299core:MoreThanFiveYears2023-06-212024-06-30SC773299core:Non-currentFinancialInstruments2024-06-30SC773299core:Non-currentFinancialInstruments2023-06-20SC773299dpl:CostSales2023-06-212024-06-30SC773299dpl:DistributionCosts2023-06-212024-06-30SC773299core:LandBuildings2023-06-212024-06-30SC773299core:PlantMachinery2023-06-212024-06-30SC773299core:Vehicles2023-06-212024-06-30SC773299core:FurnitureFittings2023-06-212024-06-30SC773299core:OfficeEquipment2023-06-212024-06-30SC773299dpl:AdministrativeExpenses2023-06-212024-06-30SC773299core:NetGoodwill2023-06-212024-06-30SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-212024-06-30SC773299dpl:GroupUndertakings2023-06-212024-06-30SC773299dpl:ParticipatingInterests2023-06-212024-06-30SC773299dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-212024-06-30SC773299core:ListedExchangeTraded2023-06-212024-06-30SC773299dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-212024-06-30SC773299core:UnlistedNon-exchangeTraded2023-06-212024-06-30SC773299dpl:CostSales2023-06-202023-06-20SC773299dpl:DistributionCosts2023-06-202023-06-20SC773299core:LandBuildings2023-06-202023-06-20SC773299core:PlantMachinery2023-06-202023-06-20SC773299core:Vehicles2023-06-202023-06-20SC773299core:FurnitureFittings2023-06-202023-06-20SC773299core:OfficeEquipment2023-06-202023-06-20SC773299dpl:AdministrativeExpenses2023-06-202023-06-20SC773299core:NetGoodwill2023-06-202023-06-20SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-202023-06-20SC773299dpl:GroupUndertakings2023-06-202023-06-20SC773299dpl:ParticipatingInterests2023-06-202023-06-20SC773299dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-202023-06-20SC773299core:ListedExchangeTraded2023-06-202023-06-20SC773299dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-202023-06-20SC773299core:UnlistedNon-exchangeTraded2023-06-202023-06-20SC773299core:NetGoodwill2024-06-30SC773299core:IntangibleAssetsOtherThanGoodwill2024-06-30SC773299core:LandBuildings2024-06-30SC773299core:PlantMachinery2024-06-30SC773299core:Vehicles2024-06-30SC773299core:FurnitureFittings2024-06-30SC773299core:OfficeEquipment2024-06-30SC773299core:AfterOneYear2024-06-30SC773299core:WithinOneYear2024-06-30SC773299core:ListedExchangeTraded2024-06-30SC773299core:UnlistedNon-exchangeTraded2024-06-30SC773299core:ShareCapital2024-06-30SC773299core:SharePremium2024-06-30SC773299core:RevaluationReserve2024-06-30SC773299core:OtherReservesSubtotal2024-06-30SC773299core:RetainedEarningsAccumulatedLosses2024-06-30SC773299core:NetGoodwill2023-06-20SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-20SC773299core:LandBuildings2023-06-20SC773299core:PlantMachinery2023-06-20SC773299core:Vehicles2023-06-20SC773299core:FurnitureFittings2023-06-20SC773299core:OfficeEquipment2023-06-20SC773299core:AfterOneYear2023-06-20SC773299core:WithinOneYear2023-06-20SC773299core:ListedExchangeTraded2023-06-20SC773299core:UnlistedNon-exchangeTraded2023-06-20SC773299core:ShareCapital2023-06-20SC773299core:SharePremium2023-06-20SC773299core:RevaluationReserve2023-06-20SC773299core:OtherReservesSubtotal2023-06-20SC773299core:RetainedEarningsAccumulatedLosses2023-06-20SC773299core:NetGoodwill2023-06-20SC773299core:IntangibleAssetsOtherThanGoodwill2023-06-20SC773299core:LandBuildings2023-06-20SC773299core:PlantMachinery2023-06-20SC773299core:Vehicles2023-06-20SC773299core:FurnitureFittings2023-06-20SC773299core:OfficeEquipment2023-06-20SC773299core:AfterOneYear2023-06-20SC773299core:WithinOneYear2023-06-20SC773299core:ListedExchangeTraded2023-06-20SC773299core:UnlistedNon-exchangeTraded2023-06-20SC773299core:ShareCapital2023-06-20SC773299core:SharePremium2023-06-20SC773299core:RevaluationReserve2023-06-20SC773299core:OtherReservesSubtotal2023-06-20SC773299core:RetainedEarningsAccumulatedLosses2023-06-20SC773299core:AfterOneYear2023-06-212024-06-30SC773299core:WithinOneYear2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:CostValuation2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-212024-06-30SC773299core:Non-currentFinancialInstrumentscore:CostValuation2024-06-30SC773299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-30SC773299core:Non-currentFinancialInstrumentscore:CostValuation2023-06-20SC773299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-20SC773299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-20SC773299bus:Director12023-06-212024-06-30SC7732991bus:Director12023-06-21SC7732991bus:Director12023-06-212024-06-30SC7732991bus:Director12024-06-30SC7732992023-06-21SC7732992023-06-212024-06-30SC7732992024-06-30

MAKIBEL LIMITED

Registered Number
SC773299
(Scotland)

Unaudited Financial Statements for the Period ended
30 June 2024

MAKIBEL LIMITED
Company Information
for the period from 21 June 2023 to 30 June 2024

Director

ALMAKI, Ahmed Alemam, Dr

Registered Address

4d Auchingramont Road
Hamilton
ML3 6JT

Place of Business

19 Captains Walk

Cleland

Motherwell

ML1 5TU


Registered Number

SC773299 (Scotland)
MAKIBEL LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

£

£

Fixed assets
Investments418,423
Investment property3456,375
474,798
Current assets
Debtors553,400
Cash at bank and on hand207,922
261,322
Creditors amounts falling due within one year6(2,500)
Net current assets (liabilities)258,822
Total assets less current liabilities733,620
Creditors amounts falling due after one year7(736,289)
Net assets(2,669)
Capital and reserves
Called up share capital100
Profit and loss account(2,769)
Shareholders' funds(2,669)
The financial statements were approved and authorised for issue by the Director on 12 February 2025, and are signed on its behalf by:
ALMAKI, Ahmed Alemam, Dr
Director
Registered Company No. SC773299
MAKIBEL LIMITED
Notes to the Financial Statements
for the period ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the service as at the balance sheet date.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Investment property
The investment property is accounted for under FRS 102, Section 16 Investment Property. Investment property is remeasured to fair value at each balance sheet date with fair value gains and losses being reported in profit or loss. Investment properties are valued using RICS open market valuation on a freehold basis.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

2024
Average number of employees during the year0
3.Investment property

£
Additions456,375
At 30 June 24456,375
4.Fixed asset investments

Other investments1

Total

££
Cost or valuation
Additions18,42318,423
At 30 June 2418,42318,423
Net book value
At 30 June 2418,42318,423

Notes

1Other investments other than loans
5.Debtors: amounts due within one year

2024

£
Amounts owed by associates and joint ventures / participating interests53,400
Total53,400
6.Creditors: amounts due within one year

2024

£
Accrued liabilities and deferred income2,500
Total2,500
7.Creditors: amounts due after one year

2024

£
Amounts owed to related parties500,500
Other creditors235,789
Total736,289
8.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
ALMAKI, Ahmed Alemam, Dr053,400053,400
053,400053,400
The above balance which is due from the director is unsecured, interest free and has no fixed repayment terms.